Literature DB >> 26175947

Tumor-suppressive microRNA-497 targets IKKβ to regulate NF-κB signaling pathway in human prostate cancer cells.

Xiang-Jie Kong1, Liu-Jian Duan1, Xiao-Qiang Qian1, Ding Xu1, Hai-Long Liu1, Ying-Jian Zhu2, Jun Qi1.   

Abstract

BACKGROUND: Prostate cancer (PCa) is one of the most prevalent malignant tumors, PCa-related death is mainly due to the high probability of metastasis. MicroRNAs (miRNAs) play an important role in cancer initiation, progression and metastasis by regulating their target genes.
METHODS: real-time PCR was used to detected the expression of microRNA-497. The molecular biological function was investigated by using cell proliferation assays, cell cycle assay, and migration and invasion assay. We used several Algorithms and confirmed that IKKβ is directly regulated by miR-497.
RESULTS: Here, we found miR-497 is downregulated in human prostate cancer (PCa) and inhibites the proliferation activity, migration and invasion of PC3-AR cells. Subsequently, IKKβ is confi rmed as a target of miR-497. Furthermore, knockdown of IKKβ expression resulted in decreased proliferation activity, migration and invasion. Finally, similar results was found after treatment with a novel IKK-β inhibitor (IMD-0354) in PC3-AR cells. CDK8, MMP-9, and PSA were involved in all these process.
CONCLUSION: Taken together, our results show evidence that miR-497 may function as a tumor suppressor genes by regulating IKK-β in PCa, and may provide a strategy for blocking PCa metastasis.

Entities:  

Keywords:  IKKβ; IMD-0354; MiR-497; PCa; invasion; migration

Year:  2015        PMID: 26175947      PMCID: PMC4497445     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  32 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

2.  Prostate cancer screening with prostate-specific antigen testing: more answers or more confusion?

Authors:  Eleftherios P Diamandis
Journal:  Clin Chem       Date:  2010-01-21       Impact factor: 8.327

3.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

4.  Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells.

Authors:  J Yang; A Richmond
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

Review 5.  MicroRNAs and metastasis: little RNAs go a long way.

Authors:  Derek M Dykxhoorn
Journal:  Cancer Res       Date:  2010-07-27       Impact factor: 12.701

Review 6.  Review of diagnostic markers for prostate cancer.

Authors:  Fritz H Schröder
Journal:  Recent Results Cancer Res       Date:  2009

7.  Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells.

Authors:  Ravikumar Aalinkeel; Madhavan P N Nair; Gerald Sufrin; Supriya D Mahajan; Kailash C Chadha; Ram P Chawda; Stanley A Schwartz
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

Review 8.  Dissection of the NF-kappaB signalling cascade in transgenic and knockout mice.

Authors:  M Pasparakis; T Luedde; M Schmidt-Supprian
Journal:  Cell Death Differ       Date:  2006-05       Impact factor: 15.828

9.  Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.

Authors:  Christina M Annunziata; R Eric Davis; Yulia Demchenko; William Bellamy; Ana Gabrea; Fenghuang Zhan; Georg Lenz; Ichiro Hanamura; George Wright; Wenming Xiao; Sandeep Dave; Elaine M Hurt; Bruce Tan; Hong Zhao; Owen Stephens; Madhumita Santra; David R Williams; Lenny Dang; Bart Barlogie; John D Shaughnessy; W Michael Kuehl; Louis M Staudt
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

10.  The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells.

Authors:  Alexander V Gasparian; Ya Juan Yao; Dariusz Kowalczyk; Ludmila A Lyakh; Apollon Karseladze; Thomas J Slaga; Irina V Budunova
Journal:  J Cell Sci       Date:  2002-01-01       Impact factor: 5.285

View more
  21 in total

1.  MiR-592 represses FOXO3 expression and promotes the proliferation of prostate cancer cells.

Authors:  Zhonghua Lv; Pinlang Rao; Wenlin Li
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  microRNA-497 overexpression decreases proliferation, migration and invasion of human retinoblastoma cells via targeting vascular endothelial growth factor A.

Authors:  Jianjun Li; Yinghui Zhang; Xiuchao Wang; Ruibo Zhao
Journal:  Oncol Lett       Date:  2017-04-24       Impact factor: 2.967

Review 3.  A step-by-step microRNA guide to cancer development and metastasis.

Authors:  Georgios S Markopoulos; Eugenia Roupakia; Maria Tokamani; Evangelia Chavdoula; Maria Hatziapostolou; Christos Polytarchou; Kenneth B Marcu; Athanasios G Papavassiliou; Raphael Sandaltzopoulos; Evangelos Kolettas
Journal:  Cell Oncol (Dordr)       Date:  2017-07-26       Impact factor: 6.730

4.  miRNA-451 regulates the NF-κB signaling pathway by targeting IKKβ to inhibit glioma cell growth.

Authors:  Yang Nan; Liyun Guo; Yingwei Zhen; Le Wang; Bingcheng Ren; Xingjie Chen; Yalin Lu; Kai Yu; Yue Zhong; Qiang Huang
Journal:  Cell Cycle       Date:  2021-08-31       Impact factor: 5.173

5.  SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497.

Authors:  Qianshan Ding; Ke He; Tao Luo; Yunchao Deng; Hanning Wang; Hao Liu; Jinqian Zhang; Kaiyun Chen; Jinfeng Xiao; Xiaopeng Duan; Rui Huang; Zhenglin Xia; Wenjie Zhou; Jinliang He; Honggang Yu; Xingyuan Jiao; Guoan Xiang
Journal:  Mol Ther       Date:  2016-01-12       Impact factor: 11.454

6.  A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.

Authors:  Giulia Regazzo; Irene Terrenato; Manuela Spagnuolo; Mariantonia Carosi; Gaetana Cognetti; Lucia Cicchillitti; Francesca Sperati; Veronica Villani; Carmine Carapella; Giulia Piaggio; Andrea Pelosi; Maria Giulia Rizzo
Journal:  J Exp Clin Cancer Res       Date:  2016-07-30

Review 7.  Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals.

Authors:  Alessandra Bosutti; Fabrizio Zanconati; Gabriele Grassi; Barbara Dapas; Sabina Passamonti; Bruna Scaggiante
Journal:  Anticancer Agents Med Chem       Date:  2016       Impact factor: 2.505

8.  MicroRNA‑497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3.

Authors:  Juhua Zhuang; Ying Ye; Guoyu Wang; Jing Ni; Saifei He; Cuihua Hu; Wei Xia; Zhongwei Lv
Journal:  Mol Med Rep       Date:  2017-08-24       Impact factor: 3.423

9.  MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.

Authors:  Sun Pengcheng; Wang Ziqi; Yin Luyao; Zhu Xiangwei; Liu Liang; Liu Yuwei; Li Lechen; Xu Wanhai
Journal:  Biosci Rep       Date:  2017-05-19       Impact factor: 3.840

10.  Identification of Recurrence-Related microRNAs from Bone Marrow in Hepatocellular Carcinoma Patients.

Authors:  Keishi Sugimachi; Shotaro Sakimura; Akira Tomokuni; Ryutaro Uchi; Hidenari Hirata; Hisateru Komatsu; Yoshiaki Shinden; Tomohiro Iguchi; Hidetoshi Eguchi; Takaaki Masuda; Kazutoyo Morita; Ken Shirabe; Hidetoshi Eguchi; Yoshihiko Maehara; Masaki Mori; Koshi Mimori
Journal:  J Clin Med       Date:  2015-08-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.